Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Obergassel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 22, 1995
[ACE inhibitor-associated interstitial lung infiltrates]L Obergassel, J Carlsson, U Tebbe
Herzschrittmachertherapie & Elektrophysiologie|October 29, 2021
[Surprising mechanism of highly symptomatic tachycardia in a young patient : Diagnosis and treatment]L Obergassel, T Feldmann, C W Israel
Medizinische Klinik (Munich, Germany : 1983)|August 7, 1999
[Typical AV nodal reentry tachycardia in 4 anterograde AV nodal pathways. Successful high frequency ablation of slow AV nodal pathways]L Obergassel, P Weismüller, K Kattenbeck, et al.
Heart (British Cardiac Society)|May 18, 2004
Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patientsF H Gietzen, C J Leuner, L Obergassel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillationL Obergassel, T Lawrenz, F H Gietzen, et al.
Zeitschrift Fur Kardiologie|May 16, 2000
Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathyH Kuhn, F H Gietzen, C Leuner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|September 22, 1995
[ACE inhibitor-associated interstitial lung infiltrates]L Obergassel, J Carlsson, U Tebbe
Herzschrittmachertherapie & Elektrophysiologie|October 29, 2021
[Surprising mechanism of highly symptomatic tachycardia in a young patient : Diagnosis and treatment]L Obergassel, T Feldmann, C W Israel
Medizinische Klinik (Munich, Germany : 1983)|August 7, 1999
[Typical AV nodal reentry tachycardia in 4 anterograde AV nodal pathways. Successful high frequency ablation of slow AV nodal pathways]L Obergassel, P Weismüller, K Kattenbeck, et al.
Heart (British Cardiac Society)|May 18, 2004
Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patientsF H Gietzen, C J Leuner, L Obergassel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2006
Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillationL Obergassel, T Lawrenz, F H Gietzen, et al.
Zeitschrift Fur Kardiologie|May 16, 2000
Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathyH Kuhn, F H Gietzen, C Leuner, et al.
Pageof 1